Search Results
PI-3065 10 mg | Purity Not Available
TargetMol
PI-3065 100 mg | Purity Not Available
TargetMol
kb NB 142-70 5 mg | Purity Not Available
TargetMol
kb NB 142-70 is a selective protein kinase D (PKD) inhibitor (IC50 values are 28.3, 58.7 and 53.2 nM for PKD1, 2 and 3 respectively).
More Information Supplier Pagekb NB 142-70 50 mg | Purity Not Available
TargetMol
kb NB 142-70 is a selective protein kinase D (PKD) inhibitor (IC50 values are 28.3, 58.7 and 53.2 nM for PKD1, 2 and 3 respectively).
More Information Supplier Pagekb NB 142-70 25 mg | Purity Not Available
TargetMol
kb NB 142-70 is a selective protein kinase D (PKD) inhibitor (IC50 values are 28.3, 58.7 and 53.2 nM for PKD1, 2 and 3 respectively).
More Information Supplier Pagekb NB 142-70 10 mg | Purity Not Available
TargetMol
kb NB 142-70 is a selective protein kinase D (PKD) inhibitor (IC50 values are 28.3, 58.7 and 53.2 nM for PKD1, 2 and 3 respectively).
More Information Supplier PageTaselisib 5 mg | 99.46%
TargetMol
Taselisib is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
More Information Supplier PageTaselisib 50 mg | 99.46%
TargetMol
Taselisib is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
More Information Supplier PageTaselisib 10 mg | 99.46%
TargetMol
Taselisib is an orally bioavailable inhibitor of the class I phosphatidylinositol 3-kinase (PI3K) alpha isoform (PIK3CA), with potential antineoplastic activity.
More Information Supplier Page
